CM
CTSO icon

CM Management’s Cytosorbents Corp CTSO Stock Holding History

CM Management’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$288K Hold
73,825
– – 0.19% 65
2026
Q2 		$552K Hold
73,825
– – 0.35% 65
2026
Q1 		$836K Hold
73,825
– – 0.7% 52
2025
Q4 		$944K Buy
73,825
+9,419
+15% +$145K 0.8% 46
2025
Q3 		$1.2M Buy
64,406
+1,906
+3% +$37.5K 1% 39
2025
Q2 		$1.6M Buy
62,500
+14,796
+31% +$297K 1.46% 28
2025
Q1 		$954K Buy
47,704
+12,704
+36% +$268K 0.96% 38
2024
Q4 		$637K Sell
35,000
-5,000
-13% -$98.1K 0.57% 48
2024
Q3 		$1.2M Sell
40,000
-2,500
-6% -$54.8K 0.96% 41
2024
Q2 		$598K Buy
42,500
+1,250
+3% +$21.7K 0.55% 50
2024
Q1 		$784K Buy
41,250
+20,500
+99% +$399K 0.66% 48
2023
Q4 		$461K Sell
20,750
-1,750
-8% -$52K 0.37% 59
2023
Q3 		$846K Hold
22,500
– – 0.9% 38
2023
Q2 		$1.62M Hold
22,500
– – 1.58% 20
2023
Q1 		$1.52M Sell
22,500
-1,250
-5% -$75K 1.8% 17
2022
Q4 		$736K Sell
23,750
-10,000
-30% -$297K 0.88% 36
2022
Q3 		$918K Buy
33,750
+3,750
+13% +$146K 1.02% 36
2022
Q2 		$1.31M Buy
30,000
+12,500
+71% +$574K 1.4% 28
2022
Q1 		$1.12M Buy
17,500
+2,500
+17% +$179K 0.94% 38
2021
Q4 		$1.26M Buy
15,000
+6,250
+71% +$701K 0.95% 33
2021
Q3 		$1.42M Buy
8,750
+1,250
+17% +$203K 1.06% 32
2021
Q2 		$1.13M Buy
7,500
+1,500
+25% +$253K 0.82% 46
2021
Q1 		$1.04M Buy
+6,000
New +$1.14M 0.77% 55

Other funds holding CTSO

Avenir Corporation
Avenir Corporation Alexandria, Virginia $812M AUM 0.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Neuberger Berman Group
Neuberger Berman Group New York $148B AUM 31.56% 1-Year Est. Return
Skylands Capital
Skylands Capital Milwaukee, Wisconsin $762M AUM 14.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $36.2B AUM 20.53% 1-Year Est. Return
Sargent Investment Group
Sargent Investment Group Bethesda, Maryland $867M AUM 20.76% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

CM Management's CTSO Position: Q3 2026 in Review

CM Management held its Cytosorbents Corp (CTSO) position steady in Q3 2026 at 73,825 shares worth $288K. The position accounts for 0.19% of the portfolio, ranked #65.

CM Management first reported a position in CTSO in Q1 2021 and has held it in 23 quarters since. The position peaked at $1.62M in Q2 2023. 25 funds tracked by Wall St. Rank hold CTSO as of Q3 2026.

  • CM Management held 73,825 shares of Cytosorbents Corp worth $288K as of Q3 2026.
  • CM Management left its Cytosorbents Corp share count unchanged in Q3 2026.
  • Cytosorbents Corp made up 0.19% of CM Management's portfolio in Q3 2026, its #65 holding.
  • CM Management first reported a position in Cytosorbents Corp in Q1 2021 and has held it in 23 quarters since.
  • CM Management's Cytosorbents Corp position peaked at $1.62M in Q2 2023.
  • 25 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2026.

Based on CM Management's 13F filing for Q3 2026, filed 12 Nov 2026.